Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
Cynthia X. Ma, … , Matthew J. Ellis, Helen Piwnica-Worms
Cynthia X. Ma, … , Matthew J. Ellis, Helen Piwnica-Worms
Published July 2, 2012
Citation Information: J Clin Invest. 2012;122(7):2702-2702. https://doi.org/10.1172/JCI64256.
View: Text | PDF | Amended Article
Erratum

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

Abstract

Authors

Cynthia X. Ma, Shirong Cai, Shunqiang Li, Christine E. Ryan, Zhanfang Guo, W. Timothy Schaiff, Li Lin, Jeremy Hoog, Reece J. Goiffon, Aleix Prat, Rebecca L. Aft, Matthew J. Ellis, Helen Piwnica-Worms

×

Full Text PDF | Download (67.53 KB)